| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000031731 |
| Receipt No. | R000036121 |
| Official scientific title of the study | Analysis of vaginal and uterine microbiota of infertile and recurrent miscarriage patients |
| Date of disclosure of the study information | 2018/03/15 |
| Last modified on | 2018/03/17 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Analysis of vaginal and uterine microbiota of infertile and recurrent miscarriage patients | |
| Title of the study (Brief title) | Analysis of vaginal and uterine microbiota of infertile and recurrent miscarriage patients | |
| Region |
|
|
| Condition | ||
| Condition | infertility and recurrent miscarriage | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To clarify the etiology of nfertility and recurrent miscarriage using vaginal and uterine microbiota |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The association between microbiota and implantation rate and livebirth rate. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -but assessor(s) are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | vaginal and uterine cavity secretion and endometrial tissue collection from test subjects | ||
| Interventions/Control_2 | vaginal and uterine cavity secretion and endometrial tissue collection from test subjects after treatments by antibiotics and/or probiotics/prebiotics administration
<antibiotics> 1. doxycycline 200mg (100mg tablet, twice a day) for 14 days 2. ciprofloxacin 600mg(200mg tablet, three times a day) for 10 days 3. amoxicillin 1000mg(250mg capsule, four times a day) for 8 days 4. josamycin 1200mg(200mg two tablets, three times a day) for 12 days <probiotics/prebiotics> 1. lactoferrin 700mg(100mg seven tablets, once time a day ) for more than four weeks |
||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Infertile patients requiring artificial reproductive technology and recurrent miscarriage patients | |||
| Key exclusion criteria | None | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Takuhiko Ichiyama |
| Organization | St.Mother Hospital |
| Division name | Department of obstetrics and gynecology |
| Address | 4-9-12 Orio Yahatanishi-ku Kitakyusyu city Fukuoka Japan |
| TEL | 81-93-601-2000 |
| peacety0218@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Takuhiko Ichiyama |
| Organization | St.Mother Hospital |
| Division name | Department of obstetrics and gynecology |
| Address | 4-9-12 Orio Yahatanishi-ku Kitakyusyu city Fukuoka Japan |
| TEL | 81-93-601-2000 |
| Homepage URL | |
| incho@stmother.com | |
| Sponsor | |
| Institute | St.Mother Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036121 |